AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States.
It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices.
The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing.
In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand.
Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com.
Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Country | United States |
IPO Date | Apr 5, 2019 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 9 |
CEO | Mark Goldstone |
Contact Details
Address: 15150 Avenue of Science San Diego, California United States | |
Website | https://www.guardionhealth.com |
Stock Details
Ticker Symbol | GHSI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001642375 |
CUSIP Number | 40145Q203 |
ISIN Number | US40145Q5009 |
Employer ID | 47-4428421 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Mark Goldstone | Interim President, Chief Executive Officer & Director |
Katie Cox | Chief Accounting Officer |
Robert Neal Weingarten | Independent Chairman & Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 26, 2024 | 8-K | Current Report |
Nov 18, 2024 | 8-K | Current Report |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 31, 2024 | 8-K | Current Report |
Oct 11, 2024 | 25 | Filing |
Oct 03, 2024 | 8-K | Current Report |
Sep 23, 2024 | 8-K | Current Report |
Aug 28, 2024 | 4 | Filing |
Aug 28, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Aug 21, 2024 | 8-K | Current Report |